Dr. Shivashankara Swamy M S

Professional Journey

Achievements

• Talk on “Ideal first-line strategy in EGFR mutated metastatic Lung Cancer” at Lung Cancer Update, Delhi chapter, October 2020
• Paper presentation on “Outcomes and prognostic factors in localized soft tissue sarcoma: Prospective observational study” at ESMO Congress September 2020
• Oral Presentation “cyclophosphamide followed by intravenous busulfan (CY-BU) As myeloablative conditioning: impact on veno-occlusive disease (VOD) and Transplant outcomes, a single centre experience” at EBMT Highlights APAC 2018, India.
• Best of SABCS, India chapter 2020 at Mumbai, India
• Indian Myeloma Congress, 2020 at Hyderabad, India
• Best of SABCS, India Chapter 2019 at Delhi, India
• Indian Myeloma Congress, 2018 at Delhi, India

Awards

• Gold medallist for being a university topper in MD medicine.
• First Prize in case Presentation at C4 – Challenging Case Capsules in Cancer, 2019 organized Max Institute of Cancer Care New Delhi
• First Prize in Adrenaline Rush Quiz 2019 organized by Max Institute of Cancer Care New Delhi
• 2nd Prize in Best of SABCS Delhi chapter quiz

Clinical Research

• MD Thesis – Prevalence of hyperprolactinemia in hypothyroid population and its clinical profile and effect of L-thyroxine on prolactin levels.
• DNB Thesis – A study of Clinico-epidemiological Profile, Histopathology and outcome of Soft Tissue sarcoma: at a Tertiary Care Centre Sub investigator
• FLAURA 2: Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
• BREAKWATER (C4221015): Randomized phase 3 study of encorafenib (enco) + cetuximab (cetux) ± chemotherapy for first line (1L) treatment (tx) of BRAF V600E-mutant (BRAFV600E) metastatic colorectal cancer (mCRC).
  Ongoing trial at institution as primary investigator
• Role of metronomic therapy in metastatic or recurrent Head and neck squamous cell carcinoma
• Prevalence and implication of DYPD mutation in rectal cancer patients
• Prevalence and risk factors for 5FU related cardiotoxicity in colorectal cancer patients

Publication

• Shivashankara, Banerjee J, Mehrotra R, Wildes TM. Improving care for older adults with hematological malignancies in India: Conquering the challenge. J Geriatr Oncol. 2023 Jul;14(6):101536. doi: 10.1016/j.jgo.2023.101536. Epub 2023 May 30. PMID: 37258397
• Shivarudraiah SS, Goyal S, Basu D, Pathak A, Jain A.How ctDNA changing the landscape of management of colorectal cancers. Indian Cancer Awareness J 2022;1:33-40.DOI: 10.25259/ICAJ_11_2022
• Shivarudraiah SM, Patel A, Singh S.Acute severe gastroparesis (mega-stomach), an unusual complication of autologous stem cell transplant: A case report,November 2022, 10.4103/crst.crst_115_21
• Shivashankara Mathighatta Shivarudraiah, Sundaram Viswanath, Suresh Pandalanghat, Adult Soft Tissue Sarcoma: A Prospective Observational Real-World Data, Indian Journal of Medical and Paediatric Oncology Vol. 42 No. 4/2021. DOI https://doi.org/ 10.1055/s-0041-1731856, ISSN 0971-585;
• Outcomes and prognostic factors in localized soft tissue sarcoma: Prospective observational study, September 2020, Annals of Oncology 31:S989. DOI:10.1016/j.annonc.2020.08.1888
• Real-world experience of treatment and outcome in ALK-rearranged metastatic non-small cell lung cancer: A multicenter study from India. Current problems in cancer.2020 www.sciencedirect.com
• Fulvestrant: Do not forget the history and opportunities for cost-saving from real-world data. Cancer Res Stat Treat 2020;3:663 (PDF) CancerResStatTreat33663-6164147-17072. https://www.researchgate.net/publication/344361031_CancerResStatTreat33663-6164147-170721_1
• Correlations of Programmed death-ligand 1Expression with gene Expression and Clinicopathological parameters in Indian patients with non-small cell Lung cancer.www.lungindia.com
• Genomic architecture of gallbladder cancer: Results of a first prospective study, May 2020, Journal of Clinical Oncology 38(15_suppl):e16628-e16628, 2020 DOI:10.1200/JCO.2020.38.15_suppl.e16628
• Pharmacogenomics, January 2020, Indian journal of medical and pediatric oncology 41(4):550. DOI:10.4103/ijmpo.ijmpo_61_20
• Shivashankara, Banerjee J, Mehrotra R, Wildes TM. Improving care for older adults with hematological malignancies in India: Conquering the challenge. J Geriatr Oncol. 2023 Jul;14(6):101536. doi: 10.1016/j.jgo.2023.101536. Epub 2023 May 30. PMID: 37258397
• Shivarudraiah SS, Goyal S, Basu D, Pathak A, Jain A.How ctDNA changing the landscape of management of colorectal cancers. Indian Cancer Awareness J 2022;1:33-40.DOI: 10.25259/ICAJ_11_2022
• Shivarudraiah SM, Patel A, Singh S.Acute severe gastroparesis (mega-stomach), an unusual complication of autologous stem cell transplant: A case report,November 2022, 10.4103/crst.crst_115_21
• Shivashankara Mathighatta Shivarudraiah, Sundaram Viswanath, Suresh Pandalanghat, Adult Soft Tissue Sarcoma: A Prospective Observational Real-World Data, Indian Journal of Medical and Paediatric Oncology Vol. 42 No. 4/2021. DOI https://doi.org/ 10.1055/s-0041-1731856, ISSN 0971-585.
• M.S. Shivashankara, S. Viswanath, S. Pandalanghat, Outcomes and prognostic factors in localized soft tissue sarcoma: Prospective observational study, September 2020, Annals of Oncology 31:S989. DOI:10.1016/j.annonc.2020.08.1888
• Amol Patel, Ullas Batra, Kuruswamy, Thurai Prasad, Shivashankara MS,Real-world experience of treatment and outcome in ALK-rearranged metastatic non-small cell lung cancer: A multicenter study from India. Current problems in cancer.2020 www.sciencedirect.com
• Patel, Amol; Shivashankara, M. S, Fulvestrant: Do not forget the history and opportunities for cost saving from real-world data. Cancer Research, Statistics, and Treatment 3(3):p 663, Jul–Sep 2020. | DOI: 10.4103/CRST.CRST_256_20
• Kumar M, Guleria B, Swamy S, Soni S. Correlation of programmed death-ligand 1 expression with gene expression and clinicopathological parameters in Indian patients with non-small cell lung cancer. Lung India. 2020 Mar-Apr;37(2):145-150. doi: 10.4103/lungindia.lungindia_488_19. PMID: 32108600; PMCID: PMC7065552.
• Amol Patel, H P Singh, Suresh Pandalanghat, Manish Kumar, Bhupesh Guleria, and Shivashankara Swamy Mathighatta Shivarudraiah. Genomic architecture of gallbladder cancer: Results of a first prospective study, May 2020, Journal of Clinical Oncology 38(15_suppl):e16628-e16628, 2020 DOI:10.1200/JCO.2020.38.15_suppl.e16628
• Shivashankara MS, Pharmacogenomics, January 2020, Indian journal of medical and pediatric oncology 41(4):550. DOI:10.4103/ijmpo.ijmpo_61_20